Qiu-ran Xu

Zhejiang Key Laboratory Of Tumor Molecular Diagnosis And Individualized Medicine
Hangzhou, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

Engineered Bacteria Factory Integrating Drug Delivery and Antibody Manufacture for Activating the STING Signal Pathway Mediated Tumor Immunotherapy.

Engineered Bacteria Factory Integrating Drug Delivery and Antibody Manufacture for Activating the STING Signal Pathway Mediated Tumor Immunotherapy.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: September 16, 2025

Effect of early peri-operative arterial lactate concentration level ratios on post-hepatectomy liver failure.

Effect of early peri-operative arterial lactate concentration level ratios on post-hepatectomy liver failure.

Journal: Discover oncology
Published: November 21, 2023

Engineering Phage Nanocarriers Integrated with Bio-Intelligent Plasmids for Personalized and Tunable Enzyme Delivery to Enhance Chemodynamic Therapy.

Engineering Phage Nanocarriers Integrated with Bio-Intelligent Plasmids for Personalized and Tunable Enzyme Delivery to Enhance Chemodynamic Therapy.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: November 03, 2023

Fatty acid transport protein-5 (FATP5) deficiency enhances hepatocellular carcinoma progression and metastasis by reprogramming cellular energy metabolism and regulating the AMPK-mTOR signaling pathway.

Fatty acid transport protein-5 (FATP5) deficiency enhances hepatocellular carcinoma progression and metastasis by reprogramming cellular energy metabolism and regulating the AMPK-mTOR signaling pathway.

Journal: Oncogenesis
Published: June 12, 2021

Long-Term Surgical Outcomes of Liver Resection for Hepatocellular Carcinoma in Patients With HBV and HCV Co-Infection: A Multicenter Observational Study.

Long-Term Surgical Outcomes of Liver Resection for Hepatocellular Carcinoma in Patients With HBV and HCV Co-Infection: A Multicenter Observational Study.

Journal: Frontiers in oncology
Published: April 25, 2021

Postoperative morbidity adversely impacts long-term oncologic prognosis following hepatectomy for hepatocellular carcinoma: A multicenter observational study.

Postoperative morbidity adversely impacts long-term oncologic prognosis following hepatectomy for hepatocellular carcinoma: A multicenter observational study.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: January 06, 2021

Early diagnosis and therapeutic strategies for hepatocellular carcinoma: From bench to bedside.

Early diagnosis and therapeutic strategies for hepatocellular carcinoma: From bench to bedside.

Journal: World journal of gastrointestinal oncology
Published: December 21, 2020

Biomarkers for hepatocellular carcinoma based on body fluids and feces.

Biomarkers for hepatocellular carcinoma based on body fluids and feces.

Journal: World journal of gastrointestinal oncology
Published: December 21, 2020

[Corrigendum] TP53 and RET may serve as biomarkers of prognostic evaluation and targeted therapy in hepatocellular carcinoma.

[Corrigendum] TP53 and RET may serve as biomarkers of prognostic evaluation and targeted therapy in hepatocellular carcinoma.

Journal: Oncology reports
Published: November 10, 2016

TP53 and RET may serve as biomarkers of prognostic evaluation and targeted therapy in hepatocellular carcinoma.

TP53 and RET may serve as biomarkers of prognostic evaluation and targeted therapy in hepatocellular carcinoma.

Journal: Oncology reports
Published: November 10, 2016
Showing 1-10 of 10

Last Updated: 09/26/2026